Suzuki, M <br/><br/>
Rational design of antitumor prostaglandins with high biological stability.  [electronic resource] 

 -  Journal of medicinal chemistry  Jul 1998 
 - 3084-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm9801657  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--blood<br/>Cell Division--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21<br/>Cyclins--biosynthesis<br/>Drug Design<br/>Drug Screening Assays, Antitumor<br/>Drug Stability<br/>G1 Phase--drug effects<br/>Humans<br/>Prostaglandins--blood<br/>Rats<br/>Stereoisomerism<br/>Structure-Activity Relationship<br/>Tumor Cells, Cultured